Spots Global Cancer Trial Database for stage iia breast cancer ajcc v6 and v7

Every month we try and update this database with for stage iia breast cancer ajcc v6 and v7 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer	NCT01266642	Ductal Breast C... Invasive Breast... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	External Beam R... External Beam R... Hypofractionate... Laboratory Biom... Quality-of-Life... Questionnaire A... Whole Breast Ir... Whole Breast Ir...	40 Years -	M.D. Anderson Cancer Center
Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC	NCT02593175	Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Triple-Negative...	Carboplatin Paclitaxel Panitumumab	18 Years -	M.D. Anderson Cancer Center
Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC	NCT02593175	Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Triple-Negative...	Carboplatin Paclitaxel Panitumumab	18 Years -	M.D. Anderson Cancer Center
The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer	NCT03454529	Invasive Breast... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Laboratory Biom... Simvastatin	19 Years -	Barbara Ann Karmanos Cancer Institute
The Role of Lifestyle Factors in Breast Cancer-Related Outcomes	NCT02079662	Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea...	Behavioral, Psy... Best Practice Cognitive Inter... Computer-Assist... Counseling Exercise Interv... Laboratory Biom... Quality-of-Life... Questionnaire A...	18 Years -	M.D. Anderson Cancer Center
Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence	NCT04054557	Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage III Breas...	Telemedicine Best Practice Questionnaire A... Quality-of-Life... Survey Administ... Behavioral Inte... Educational Int...	18 Years -	Thomas Jefferson University
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery	NCT00861705	Male Breast Car... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Triple-Negative...	Bevacizumab Carboplatin Cyclophosphamid... Doxorubicin Hyd... Laboratory Biom... Paclitaxel	18 Years -	National Cancer Institute (NCI)
SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast Cancer	NCT03411070	Positive Axilla... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea...	Implanted Medic... Therapeutic Con...	18 Years -	Jonsson Comprehensive Cancer Center
Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative	NCT02276443	Invasive Breast... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Triple-Negative...	Chemotherapy Immunotherapy Laboratory Biom... Lymph Node Biop... Ultrasonography	18 Years -	M.D. Anderson Cancer Center
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer	NCT02598557	Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Exemestane Laboratory Biom... Pharmacological... Placebo Adminis... Quality-of-Life... Questionnaire A... Therapeutic Con...	- 75 Years	National Cancer Institute (NCI)
Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery	NCT03317405	Breast Ductal C... Breast Lobular ... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea...	Endoxifen Hydro... Placebo Adminis... Questionnaire A...	18 Years -	National Cancer Institute (NCI)
Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After Surgery	NCT02654119	HER2 Positive B... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Cyclophosphamid... Laboratory Biom... Paclitaxel Trastuzumab	20 Years -	University of Nebraska
Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer	NCT02689427	Invasive Breast... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Triple-Negative...	Axillary Lymph ... Enzalutamide Laboratory Biom... Lymph Node Biop... Paclitaxel Therapeutic Con...	18 Years -	M.D. Anderson Cancer Center
Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC	NCT02593175	Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Triple-Negative...	Carboplatin Paclitaxel Panitumumab	18 Years -	M.D. Anderson Cancer Center
Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer	NCT00005970	Breast Adenocar... HER2 Positive B... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea...	Aromatase Inhib... Cyclophosphamid... Doxorubicin Hyd... Laboratory Biom... Paclitaxel Tamoxifen Citra... Trastuzumab	18 Years -	National Cancer Institute (NCI)
Kindness Interventions in Enhancing Well-Being in Breast Cancer Survivors	NCT03319342	Cancer Survivor Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea...	Behavioral Inte... Behavioral Inte... Behavioral Inte... Behavioral Inte... Questionnaire A...	19 Years -	Jonsson Comprehensive Cancer Center
Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer	NCT03012100	Bilateral Breas... Breast Inflamma... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Triple-Negative... Unilateral Brea...	Cyclophosphamid... Laboratory Biom... Multi-epitope F... Placebo Adminis... Sargramostim	18 Years -	Academic and Community Cancer Research United
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)	NCT00310180	Breast Adenocar... Hormone Recepto... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIB Brea...	Anastrozole Exemestane Laboratory Biom... Letrozole Quality-of-Life... Radiation Thera... Tamoxifen Citra...	18 Years - 75 Years	National Cancer Institute (NCI)
The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer	NCT03454529	Invasive Breast... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Laboratory Biom... Simvastatin	19 Years -	Barbara Ann Karmanos Cancer Institute
The Role of Lifestyle Factors in Breast Cancer-Related Outcomes	NCT02079662	Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea...	Behavioral, Psy... Best Practice Cognitive Inter... Computer-Assist... Counseling Exercise Interv... Laboratory Biom... Quality-of-Life... Questionnaire A...	18 Years -	M.D. Anderson Cancer Center
Kindness Interventions in Enhancing Well-Being in Breast Cancer Survivors	NCT03319342	Cancer Survivor Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea...	Behavioral Inte... Behavioral Inte... Behavioral Inte... Behavioral Inte... Questionnaire A...	19 Years -	Jonsson Comprehensive Cancer Center
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)	NCT00310180	Breast Adenocar... Hormone Recepto... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIB Brea...	Anastrozole Exemestane Laboratory Biom... Letrozole Quality-of-Life... Radiation Thera... Tamoxifen Citra...	18 Years - 75 Years	National Cancer Institute (NCI)
Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer	NCT03077841	Ductal Breast C... Early-Stage Bre... Invasive Breast... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Laboratory Biom... Partial Breast ... Questionnaire A...	50 Years -	M.D. Anderson Cancer Center
Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative	NCT02276443	Invasive Breast... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Triple-Negative...	Chemotherapy Immunotherapy Laboratory Biom... Lymph Node Biop... Ultrasonography	18 Years -	M.D. Anderson Cancer Center
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer	NCT02598557	Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Exemestane Laboratory Biom... Pharmacological... Placebo Adminis... Quality-of-Life... Questionnaire A... Therapeutic Con...	- 75 Years	National Cancer Institute (NCI)
Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer	NCT03077841	Ductal Breast C... Early-Stage Bre... Invasive Breast... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Laboratory Biom... Partial Breast ... Questionnaire A...	50 Years -	M.D. Anderson Cancer Center
Sensorimotor Rehabilitation Program in Improving Quality of Life in Patients With Early Stage Breast Cancer	NCT03568526	Peripheral Neur... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Educational Int... Exercise Interv... Quality-of-Life... Questionnaire A... Survey Administ...	-	Ohio State University Comprehensive Cancer Center
Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery	NCT00770809	Male Breast Car... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea...	Laboratory Biom... Lapatinib Ditos... Paclitaxel Trastuzumab	18 Years -	National Cancer Institute (NCI)
Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer	NCT02003209	HER2-Positive B... Hormone Recepto... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea...	Aromatase Inhib... Carboplatin Cytology Specim... Docetaxel Goserelin Aceta... Laboratory Biom... Pertuzumab Quality-of-Life... Therapeutic Con... Trastuzumab Whole Breast Ir...	18 Years -	National Cancer Institute (NCI)
Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer	NCT01245712	Breast Adenocar... Ductal Breast C... Invasive Breast... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Accelerated Par... Proton Beam Rad... Quality-of-Life...	18 Years -	M.D. Anderson Cancer Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: